Afficher la notice abrégée

Human cryptosporidiosis in immunodeficient patients in France (2015–2017)

dc.rights.licenseopenen_US
hal.structure.identifierCHU Rouen
dc.contributor.authorCOSTA, Damien
dc.contributor.authorRAZAKANDRAINIBE, Romy
dc.contributor.authorSAUTOUR, Marc
dc.contributor.authorVALOT, Stéphane
dc.contributor.authorBASMACIYAN, Louise
dc.contributor.authorGARGALA, Gilles
dc.contributor.authorFAVENNEC, Loïc
dc.contributor.authorDALLE, Frédéric
dc.contributor.authorDEBOURGOGNE, Anne
dc.contributor.authorANGOULVANT, Adela
dc.contributor.authorAGNAMEY, Patrice
dc.contributor.authorBONHOMME, Julie
dc.contributor.authorDEGEILH, Brigitte
dc.contributor.authorCHEMLA, Cathy
dc.contributor.authorGARNAUD, Cécile
dc.contributor.authorLOLLIVIER, Coralie
dc.contributor.authorANGEBAULT, Cécile
dc.contributor.authorDELAUNAY, Pascal
dc.contributor.authorDESOUBEAUX, Guillaume
dc.contributor.authorFREALLE, Emilie
dc.contributor.authorGRENOUILLET, Frédéric
dc.contributor.authorMORIO, Florent
dc.contributor.authorBOTTEREL, Françoise
hal.structure.identifierAnofel Cryptosporidium National Network
dc.contributor.authorBELKADI, Ghania
dc.contributor.authorYERA, Hélène
dc.contributor.authorNEVEZ, Gilles
hal.structure.identifierCHU Bordeaux
dc.contributor.authorIRIART, Xavier
hal.structure.identifierMicrobiologie Fondamentale et Pathogénicité [MFP]
dc.contributor.authorACCOCEBERRY, Isabelle
dc.contributor.authorBRUNET, Julie
dc.contributor.authorTHELLIER, Marc
dc.contributor.authorLEMETEIL, Denis
dc.contributor.authorRABODONIRINA, Meja
dc.contributor.authorSASSO, Milène
dc.contributor.authorMIOSSEC, Charline
hal.structure.identifierAnofel Cryptosporidium National Network
dc.contributor.authorNICOLAS, Murielle
dc.contributor.authorDESBOIS, Nicole
dc.contributor.authorPOIRIER, Philippe
dc.contributor.authorPOMARES, Christelle
dc.contributor.authorHOUZÉ, Sandrine
hal.structure.identifierAnofel Cryptosporidium National Network
dc.contributor.authorLE GOVIC, Yohann
dc.contributor.authorBELLANGER, Anne Pauline
dc.contributor.authorLABBE, Franck
dc.contributor.authorDARDÉ, Marie Laure
dc.contributor.authorDUQUESNOY, Olivier
dc.contributor.authorFLORI, Pierre
dc.contributor.authorBASTIEN, Patrick
dc.contributor.authorGUEUDET, Thomas
dc.contributor.authorVILLENA, Isabelle
dc.contributor.authorVOUTQUENNE-NAZABADIOKO, Laurence
dc.contributor.authorCATEAU, Estelle
dc.contributor.authorBOUGNOUX, Marie-Elisabeth
dc.contributor.authorKAPEL, Nathalie
dc.contributor.authorDANNAOUI, Eric
dc.contributor.authorVALENTIN, Alexis
dc.contributor.authorTOTET, Anne
dc.contributor.authorMENOTTI, Jean
dc.contributor.authorBLANCHET, Denis
dc.contributor.authorDEMAR, Magalie Pierre
dc.contributor.authorDUTOIT, Emmanuel
dc.contributor.authorPIARROUX, Renaud
dc.contributor.authorSITTERLÉ, Emilie
dc.contributor.authorMAGNE, Denis
dc.contributor.authorHAMANE, Samsa
dc.contributor.authorBERRY, Antoine
dc.contributor.authorRAMADE, Cecile
dc.date.accessioned2023-06-21T15:00:53Z
dc.date.available2023-06-21T15:00:53Z
dc.date.issued2018-09
dc.identifier.issn0014-4894en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/182755
dc.description.abstractEnCryptosporidiosis is a common disease in children and immunodeficient individuals. In 2006, a national network was set up on the surveillance of human cryptosporidiosis in France. Since January 2015, the 41 tertiary care hospitals and the 3 private laboratories of the French National Network on the surveillance of human cryptosporidiosis have been able to declare confirmed cases of cryptosporidiosis online. Between 2015 and 2017, 210 cases of cryptosporidiosis were declared in immunodeficient patients in France; Cryptosporidium parvum and Cryptosporidium hominis represented 66% and 22% of cases, respectively. A peak was observed in autumn. Cryptosporidiosis occurred mainly in a context of solid organ transplantation (SOT) (49%) and of HIV infection (30%). In SOT recipients, cryptosporidiosis appeared more frequently in the first 6 months post transplantation. Regarding cases declared in SOT recipients, mycophenolate mofetil was used in 68%. A mortality rate of 6% was observed. Present results underline the importance of screening for cryptosporidiosis in immunocompromised patients suffering from diarrhea, especially in the course of major cell mediated immunodeficiency or even systematic screening before SOT. Exclusive Cryptosporidium free water feeding could be suggested during major cell mediated immunodeficiency.
dc.language.isoENen_US
dc.subject.enCryptosporidiosis
dc.subject.enImmunocompromised
dc.subject.enProtozoan
dc.subject.enEpidemiology
dc.subject.enFrance
dc.title.enHuman cryptosporidiosis in immunodeficient patients in France (2015–2017)
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.exppara.2018.08.001en_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologie/Mycologieen_US
dc.subject.halSciences du Vivant [q-bio]/Microbiologie et Parasitologie/Parasitologieen_US
bordeaux.journalExperimental Parasitologyen_US
bordeaux.page108-112en_US
bordeaux.volume192en_US
bordeaux.hal.laboratoriesMFP (Laboratoire Microbiologie Fondamentale et Pathogénicité) - UMR 5234en_US
bordeaux.institutionCNRSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
bordeaux.import.sourcehal
hal.identifierhal-02902544
hal.version1
hal.exportfalse
workflow.import.sourcehal
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Experimental%20Parasitology&rft.date=2018-09&rft.volume=192&rft.spage=108-112&rft.epage=108-112&rft.eissn=0014-4894&rft.issn=0014-4894&rft.au=COSTA,%20Damien&RAZAKANDRAINIBE,%20Romy&SAUTOUR,%20Marc&VALOT,%20St%C3%A9phane&BASMACIYAN,%20Louise&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée